Calculated based on number of publications stored in Pure and citations from Scopus
20132021

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

Eri Katsuyama

Person: Academic

Hiroyuki Hirano

  • SHI Accelerator Service Ltd.
  • SHI Accelerator Service Ltd.

External person

Shoya Yamada

  • Division of Pharmaceutical Sciences
  • Okayama University
  • Japan Society for the Promotion of Science
  • Research Fellowship Division

External person

Masaki Watanabe

  • Okayama University
  • Division of Pharmaceutical Sciences
  • Division of Pharmaceutical Sciences

External person

Osamu Shibahara

  • Okayama University
  • Division of Pharmaceutical Sciences
  • Division of Pharmaceutical Sciences

External person

Shunsuke Nakatani

  • Okayama University
  • Division of Pharmaceutical Sciences

External person

Eiichi Ozeki

  • Shimadzu Corporation
  • Technology Research Laboratory

External person

Yuta Takamura

  • Division of Pharmaceutical Sciences
  • Okayama University

External person

Eiji Ando

  • Life Science Business Department
  • Shimadzu Corporation

External person

S. Zeggar

  • Okayama University
  • Department of Nephrology
  • Graduate School of Medicine
  • Department of Nephrology

External person

Arum Tri Wahyuningsih

  • Okayama University
  • Department of Cell Chemistry
  • Gadjah Mada University

External person

Midori Shinohara

  • Medical & Biological Laboratories Co, Ltd

External person

Shunsuke Irie

  • Okayama University
  • Graduate School of Natural Science and Technology
  • Graduate School of Natural Sci. and Tech.

External person

Michiko Fujihara

  • Division of Pharmaceutical Sciences
  • Okayama University
  • AIBIOS Co. Ltd. Tri-Seven Roppongi
  • AIBIOS Company. Ltd.

External person

Hirotaka Uji

  • Kyoto University

External person

Akihiro Tai

  • Faculty of Life and Environmental Sciences
  • Prefectural University of Hiroshima

External person

Melissa Siaw Han Lim

  • Okayama University

External person

Lianhua Shen

  • Shimadzu Corporation
  • Okayama University
  • Collaborative Research Center (OMIC)
  • Department of Cell Chemistry
  • Department of Cell Chemistry
  • Technology Research Laboratory
  • Department of Bacteriology
  • Departments of 1Bacteriology
  • Department of Cell Chemistry
  • Collaborative Research Center for OMIC
  • Department of Cell Chemistry
  • Zunyi Medical University

External person

Tadakatsu Mandai

  • Okayama University
  • Kurashiki University of Science and the Arts
  • Department of Life Science
  • Faculty of Life Science

External person

Masaaki Yoden

  • Okayama University
  • Graduate School of Natural Science and Technology

External person

Yuki Furusawa

  • Okayama University
  • Division of Pharmaceutical Sciences
  • Division of Pharmaceutical Sciences

External person

Eiji Ohno

  • Kyushu University of Health and Welfare
  • Kyoto Tachibana University

External person

Sumie Hiramatsu

  • Okayama University
  • Department of Nephrology
  • Department of Nephrology

External person

Hiromasa Yakushiji

  • University of Health and Welfare
  • Okayama University
  • Kyushu University of Health and Welfare

External person

N. T. Tatebe

  • Okayama University
  • Graduate School of Medicine
  • Department of Nephrology
  • Department of Medicine and Clinical Science
  • Department of Nephrology

External person

Mariko Kawamoto

  • Kurashiki University of Science and the Arts
  • Department of Life Science

External person

Toshiki Kobayashi

  • Okayama University
  • Division of Pharmaceutical Sciences
  • Division of Pharmaceutical Sciences

External person

Katsue Sunahori Watanabe

  • Okayama University
  • Department of Nephrology
  • Chugoku Central Hospital

External person

Kazunobu Yuri

  • Okayama University
  • Graduate School of Natural Science and Technology

External person

Yoshiro Kishi

  • Medical & Biological Laboratories Co, Ltd

External person